PRAIS Two perspectives. Current cancer pain research 12/4/2015. More complex thinking in cancer pain studies. Usual thinking in cancer pain studies

Size: px
Start display at page:

Download "PRAIS Two perspectives. Current cancer pain research 12/4/2015. More complex thinking in cancer pain studies. Usual thinking in cancer pain studies"

Transcription

1 PRC European Palliative Care Research Centre PRAIS The Palliative Radiotherapy And Study PRAIS Two perspectives Predict response from radiotherapy given for bone cancer Pål Klepstad Dept. Intensive Care Medicine St Olavs University Hospital Trondheim, Norway Current cancer research Typically cancer studies inclusion criteria are: Age > 18 years Evidence of malignant disease intensity NRS > 3 (moderate or severe ) Able to comply with study procedures What we actually do say is that for cancer in relation to one size fits all. Are these cancers equal? Usual thinking in cancer studies More comple thinking in cancer studies Analgesics Tumor biology Analgesics Surrounding tissue Personality factors intensity Compression distention of structures CNS changes Personality factors intensity 1

2 Mechanisms of cancer induced bone Immune cells involved in tumor and in the tumor surroundings. Immune signals influence CNS function is linked to several symptoms in cancer Drawing R. Habberstad Lozano Ondoua et al, Neurosci Lett Middlemiss et al, Clin Oncol Watkins et al, Science Direct 2006: CRP and cancer is related Il 6 and cancer is related inflammation genes and cancer are related PTGS2 gene NFKBIA gene IL 8 gene IL 6 gene IL 8 gene IL 6 The Palliative Radiotherapy And Study PRAIS Palliative radiotherapy of bone metastasis. Classification, inflammatory biomarkers, and longitudinal clinical follow up 2

3 Study Design Ph.D project: Ragnhild Habberstad Study coordinator: Trude Camilla Salvesen Centers: Trondheim, Oslo, Ålesund, Milan, Edinburgh/Glasgow, Amman, Lleida The study will include 1000 adult patients in a multicenter, multinational longitudinal observation study of patients administered for bone cancer. COMMISSION ITEM INCLUSION 3 WEEKS 8 WEEKS 16 WEEKS 24 WEEKS 1 YEAR Health care provider Screening for inclusion -Doctor Hospitalization Simplified the table translates to that we will follow Concomitant diseases Planned radiotherapy Educational status X Department category Living situation Previous treatment New cancer treatment Previous anti-cancer treatment Ongoing anti-cancer treatment Medication Pathological fractures Oncological status Karnofsky Performance Status Episodic question Survival status Cacheia Depression Before and after and For one year Health care provider CT-scan for bodycomposition () () () () () -Radiation therapist Blood for biobank Blood for biochemical analysis Weight / height Patient Blood samples PG-SGA In cancer patients intensities Episodic questions LANSS EOC QLQ-C15 Primary Current situation biomarkers predictors of response to palliative for bone cancer? All have Response Less No response Still 3

4 Optimal aim Predict response from for bone cancer All have Set of predictors for response given not given free interventions Which inflammatory substances are associated with cancer? A clinical eperimental set up. relief Not relief One year follow up cacheia in patients with metastatic cancer disease? depression in patients with metastatic cancer disease? in patients with metastatic cancer disease? 4

5 Sum it up As for other s basic research is needed As for other s clinical research is needed Future goal is targeted treatment on the origin of cancer 5

Steps towards an international classification system for cancer pain

Steps towards an international classification system for cancer pain 1 EPCRC Steps towards an international classification system for cancer pain Stein Kaasa Ghent, 18 October, 2012 Cancer Clinic St. Olavs University Hospital, Trondheim, Norway Background 2 Pain Background:

More information

Integration of palliative care into oncology

Integration of palliative care into oncology 1 Integration of palliative care into oncology Stein Kaasa European Palliative Care Research Centre, Faculty of Medicine, NTNU and Department of Oncology, St. Olavs Hospital, Trondheim University Hospital

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 15:12:21 GMT) CTRI Number Last Modified On 22/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Managing Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018

Managing Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018 Managing Bone Pain in Metastatic Disease Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018 None Disclosures Managing Bone Pain in Metastatic Disease This lecture will

More information

Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC)

Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC) 1 Dr Barry Laird Clinician Scientist in Palliative Medicine University of Edinburgh and the European Palliative Care Research Centre (PRC) 2 Acknowledgements Prof Marie Fallon (group lead EPAS) University

More information

Radiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management

Radiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management Session 5: Symptoms management Radiotherapy symptoms control in bone mets Francesco Cellini GemelliART Ernesto Maranzano,MD Director of Oncology Department Chief of Radiation Oncology Centre S. Maria Hospital

More information

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis?

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Thomas André Ankill Kämpe 30.05.2016 MED 3950,-5 year thesis Profesjonsstudiet i medisin

More information

DRAFT FOR CONSULTATION. Clinical Commissioning Policy Proposition: Palliative radiotherapy for bone pain

DRAFT FOR CONSULTATION. Clinical Commissioning Policy Proposition: Palliative radiotherapy for bone pain Clinical Commissioning Policy Proposition: Palliative radiotherapy for bone pain Information Reader Box (IRB) to be inserted on inside front cover for documents of 6 pages and over, with Publications Gateway

More information

bone HEALTH IN FOCUS UNDERSTANDING THE IMPORTANCE OF BONE HEALTH WHEN LIVING WITH METASTATIC BREAST CANCER

bone HEALTH IN FOCUS UNDERSTANDING THE IMPORTANCE OF BONE HEALTH WHEN LIVING WITH METASTATIC BREAST CANCER bone HEALTH IN FOCUS UNDERSTANDING THE IMPORTANCE OF BONE HEALTH WHEN LIVING WITH METASTATIC BREAST CANCER IF YOU VE BEEN DIAGNOSED WITH METASTATIC BREAST CANCER (ALSO KNOWN AS STAGE IV BREAST CANCER),

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Proposed Health Technology Appraisal Radium-223 chloride for the treatment of bone metastases in castrate resistant prostate cancer Draft scope Draft

More information

Metastatic Bone Adenocarcinoma with Positive TTF-1 Tumor Stain with a Lung Mass: the Role and Treatment Consideration of RT

Metastatic Bone Adenocarcinoma with Positive TTF-1 Tumor Stain with a Lung Mass: the Role and Treatment Consideration of RT Metastatic Bone Adenocarcinoma with Positive TTF-1 Tumor Stain with a Lung Mass: the Role and Treatment Consideration of RT Case Number: RT2009-74(M) Potential Audiences: Intent Doctor, Oncology Special

More information

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer 98 Journal of Pain and Symptom Management Vol. 45 No. June Original Article Changes Over Time in Occurrence, Severity, and Distress of Common Symptoms During and After Radiation Therapy for Breast Cancer

More information

Original Article on Palliative Radiotherapy

Original Article on Palliative Radiotherapy Original Article on Palliative Radiotherapy Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ- BM22: results of a Brazilian

More information

11/3/2016. Outcomes Watching It Grow. What will we discuss? GATRA Annual Conference 2016 Lisa Connor, CTR

11/3/2016. Outcomes Watching It Grow. What will we discuss? GATRA Annual Conference 2016 Lisa Connor, CTR Outcomes Watching It Grow GATRA Annual Conference 2016 Lisa Connor, CTR The abstract begins after case finding The abstract is in progress The abstract is complete The abstract is revisited and nurtured

More information

Second Single 4 Gy Reirradiation for Painful Bone Metastasis

Second Single 4 Gy Reirradiation for Painful Bone Metastasis 26 Journal of Pain and Symptom Management Vol. 23 No. 1 January 2002 Original Article Second Single 4 Gy Reirradiation for Painful Bone Metastasis Branislav Jeremic, MD, PhD, Yuta Shibamoto, MD, DMSc,

More information

Stereotactic Ablative Radiotherapy for Prostate Cancer

Stereotactic Ablative Radiotherapy for Prostate Cancer Stereotactic Ablative Radiotherapy for Prostate Cancer Laurie Cuttino, MD Associate Professor of Radiation Oncology VCU Massey Cancer Center Director of Radiation Oncology Sarah Cannon Cancer Center at

More information

JMSCR Vol 06 Issue 12 Page December 2018

JMSCR Vol 06 Issue 12 Page December 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.15 Single Institutional Comparative

More information

TIP SHEET: TARGETED RADIATION FOR CHILDHOOD CANCER AND PROGRESS IN LOWERING TREATMENT COSTS AMONG RESEARCH PRESENTATIONS BY JOHNS HOPKINS SCIENTISTS

TIP SHEET: TARGETED RADIATION FOR CHILDHOOD CANCER AND PROGRESS IN LOWERING TREATMENT COSTS AMONG RESEARCH PRESENTATIONS BY JOHNS HOPKINS SCIENTISTS Johns Hopkins Kimmel Cancer Center Office of Public Affairs Media Contacts: Vanessa Wasta, 410-614-2916, wasta@jhmi.edu Amy Mone, 410-614-2915, amone@jhmi.edu TIP SHEET: TARGETED RADIATION FOR CHILDHOOD

More information

Metastatic Disease of the Proximal Femur

Metastatic Disease of the Proximal Femur CASE REPORT Metastatic Disease of the Proximal Femur WI Faisham, M.Med{Ortho)*, W Zulmi, M.S{Ortho)*, B M Biswal, MBBS** 'Department of Orthopaedic, "Department of Oncology and Radiotherapy, School of

More information

Spinal cord compression as a first presentation of cancer: A case report

Spinal cord compression as a first presentation of cancer: A case report J Pain Manage 2013;6(4):319-322 ISSN: 1939-5914 Nova Science Publishers, Inc. Spinal cord compression as a first presentation of cancer: A case report Nicholas Lao, BMSc(C), Michael Poon, MD(C), Marko

More information

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful

More information

Ripamonti C, et al. ASCO 2012 (Abstract 9005)

Ripamonti C, et al. ASCO 2012 (Abstract 9005) ZOOM: A Prospective, Randomized Trial of Zoledronic Acid for Long-term Treatment in Patients With Bone-Metastatic Breast Cancer After 1 Year of Standard Zoledronic Acid Treatment D. Amadori, M. Aglietta,

More information

Bone metastases of solid tumors Diagnosis and management by

Bone metastases of solid tumors Diagnosis and management by Bone metastases of solid tumors Diagnosis and management by Dr/RASHA M Abd el Motagaly oncology consultant Nasser institute adult oncology unit 3/27/2010 1 Goals 1- Know the multitude of problem of bone

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

Radiopharmaceuticals for treating CRPC patients with metastatic bone disease 2014/6/27

Radiopharmaceuticals for treating CRPC patients with metastatic bone disease 2014/6/27 Radiopharmaceuticals for treating CRPC patients with metastatic bone disease 和信醫院黃玉儀 2014/6/27 Bone metastases in prostate cancer The most common site of metastasis in prostate cancer In >90% patients

More information

Early Integration of Palliative Care

Early Integration of Palliative Care Early Integration of Palliative Care Dr. Camilla Zimmermann Head, Palliative Care Program University Health Network Toronto November 1, 2014 www.fpon.ca Early Integration of Palliative Care: Evidence and

More information

Brain tumours and NHS England

Brain tumours and NHS England Brain tumours and NHS England Andrew Brodbelt Consultant Neurosurgeon and Division Clinical Director The Walton Centre NHS Foundation Trust, Liverpool NCRAS CNS tumours workshop April 12 th 2016. National

More information

Clinical Case Conference

Clinical Case Conference Clinical Case Conference Palliative radiation therapy for bone metastasis Jeff Burkeen, MD, PGY2 7/20/2015 1 Overview Epidemiology Pathophysiology Common presentations and symptoms Imaging Surgery Radiation

More information

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS MSCC CARE PATHWAYS & CASE STUDIES By Michael Balloch Spine CNS Aims To be familiar with the routes of MSCC prentaion How the guidelines work in practice Routes of presentation Generic intervention Managing

More information

Translational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen

Translational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen Translational Radiation Oncology, Physics & Supportive Care (TROP) Mark De Ridder, Wim Distelmans & Dirk Verellen Tumor hypoxia: perfusion and diffusion limited oxygenation Hypoxia acute chronic 100 100

More information

Metastatic Spinal Cord Compression

Metastatic Spinal Cord Compression Metastatic Spinal Cord Compression Dr Zacharias Tasigiannopoulos Clinical Oncologist Colney centre Department of Oncology Norwich, UK Introduction 2-5% of cancer patients have an episode of MSCC Initial

More information

Evaluation of Cancer Outcomes Barwon South West Registry

Evaluation of Cancer Outcomes Barwon South West Registry Evaluation of Cancer Outcomes Barwon South West Registry Data Request Form Applicant details Applicant name: Position: Email: Project start date: Date: Telephone: Project completion date: Project details

More information

Survival and stability of patients with urothelial cancer and spinal bone metastases after palliative radiotherapy

Survival and stability of patients with urothelial cancer and spinal bone metastases after palliative radiotherapy Radiology and Oncology Ljubljana Slovenia www.radioloncol.com research article 1 Survival and stability of patients with urothelial cancer and spinal bone metastases after palliative radiotherapy Robert

More information

Evaluation of prognostic scoring systems for bone metastases using single center data

Evaluation of prognostic scoring systems for bone metastases using single center data MOLECULAR AND CLINICAL ONCOLOGY 3: 1361-1370, 2015 Evaluation of prognostic scoring systems for bone metastases using single center data HIROFUMI SHIMADA 1, TAKAO SETOGUCHI 2, SHUNSUKE NAKAMURA 1, MASAHIRO

More information

Imaging of bone metastases

Imaging of bone metastases Imaging of bone metastases Antoine Feydy Service de Radiologie B Hôpital Cochin APHP Université Paris Descartes antoine.feydy@aphp.fr MEXICO 2016 INTRODUCTION Diagnostic Imaging Imaging Modalities Strengths,

More information

Brain Tumors. What is a brain tumor?

Brain Tumors. What is a brain tumor? Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain

More information

ONCOLOGY NUTRITION TEST SPECIFICATIONS

ONCOLOGY NUTRITION TEST SPECIFICATIONS I. NUTRITION ASSESSMENT AND DIAGNOSIS (36%) This area includes the fundamental knowledge the oncology nutrition dietitian should possess regarding cancer and treatment modalities. This knowledge enables

More information

Treatment of Brain Metastases

Treatment of Brain Metastases 1 Treatment of Brain Metastases An Overview and Pending Research Questions To Answer Olav E. Yri, MD, PhD www.ntnu.no/prc European Palliative Care Research Centre (PRC) The brain metastases diagnosis Outline

More information

Palliative radiotherapy in lung cancer

Palliative radiotherapy in lung cancer New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer

More information

Targeting and Treating Cancer

Targeting and Treating Cancer Targeting and Treating Cancer Mark R. Baker, Chief Executive Officer Jefferies Healthcare Conference June 2015 Disclosure Notice This presentation may contain projections and other forward-looking statements

More information

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma. Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest

More information

Moving on - the next step in developing an International Classification System for Cancer Pain

Moving on - the next step in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk, Pablo Amigo, Amanda Brisebois, Sarah Burton Macleod, Rebekah Gilbert, Yoko Tarumi, Vincent Thai, Gary Wolch, Lara Fainsinger & Viki Muller Division of Palliative Care

More information

Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer

Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer Esten S. Nakken MD PhD Division of Cancer Medicine Oslo University Hospital

More information

Neuro-Oncology Resident Rotation

Neuro-Oncology Resident Rotation Neuro-Oncology Resident Rotation Background. The past decade has witnessed significant strides in our ability to manage breast, lung, colon, and prostate cancer. These advances are a direct result of our

More information

Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased

Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased analysis Roel Schlijper Fellow Radiation Oncology BC Cancer, Prince George Disclosures No conflicts

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

Radiotherapy physics & Equipments

Radiotherapy physics & Equipments Radiotherapy physics & Equipments RAD 481 Lecture s Title: An Overview of Radiation Therapy for Health Care Professionals Dr. Mohammed Emam Vision :IMC aspires to be a leader in applied medical sciences,

More information

Referring to Part of the Dossier. Protocol No.: DEP1501 EudraCT/IND No.:

Referring to Part of the Dossier. Protocol No.: DEP1501 EudraCT/IND No.: 2. SYNOPSIS Name of Sponsor: Mundipharma Research Limited Name of Finished Product: epocyte Name of Active Ingredient: Cytarabine Liposome Injection INIVIUAL STUY TABLE Referring to Part of the ossier

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

One stop shop. Natalie D. Klass, MD

One stop shop. Natalie D. Klass, MD One stop shop Natalie D. Klass, MD AERO Academy Conference Innovation & Safety Lisbon 26th and 27th January 2018 Disclosure & Disclaimer An honorarium is provided by Accuray for this presentation The views

More information

Scandinavian Sarcoma Group. Ass. Prof. Otte Brosjö,, Karolinska Hospital, Stockholm

Scandinavian Sarcoma Group. Ass. Prof. Otte Brosjö,, Karolinska Hospital, Stockholm Scandinavian Sarcoma Group Ass. Prof. Otte Brosjö,, Karolinska Hospital, Stockholm The Scandinavian Sarcoma Group Organisation of Care and Research Quality management - the SSG experience Multidisciplinary

More information

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma British Journal of Haematology, 1997, 97, 29 37 Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma FINN WISLØFF 1 AND MARTIN HJORTH 2 for the

More information

Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making. Charles Cleeland MD Anderson Cancer Center

Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making. Charles Cleeland MD Anderson Cancer Center Integrating Pain Metrics into Oncologic Clinical and Regulatory Decision-Making Charles Cleeland MD Anderson Cancer Center Panelists Charles Cleeland, Department Chair, Department of Symptom Research,

More information

Management of Brain Metastases Sanjiv S. Agarwala, MD

Management of Brain Metastases Sanjiv S. Agarwala, MD Management of Brain Metastases Sanjiv S. Agarwala, MD Professor of Medicine Temple University School of Medicine Chief, Oncology & Hematology St. Luke s Cancer Center, Bethlehem, PA, USA Incidence (US):

More information

Cancer Prevention and Treatment

Cancer Prevention and Treatment Cancer Prevention and Treatment MUDr. Jiří Běhounek President of the Vysočina Region Vice-Chair, Council of the Association of Regions of the Czech Republic Chair of the Association s Commission for Health

More information

Submission from xxxxxxxxxxxxxxxxxxxxxx/xxxxxxxxxxxxxxx of Let's Face It a Support Network for the facially disfigured.

Submission from xxxxxxxxxxxxxxxxxxxxxx/xxxxxxxxxxxxxxx of Let's Face It a Support Network for the facially disfigured. From: xxxxxxxxxxxxxxxxxxxxxxx Sent: 12 September 2008 16:04 To: Jeremy Powell Subject: Re: NICE Appraisal: Head and neck cancer (squamous cell carcinoma) - cetuximab Single Technology Appraisal (STA) Appraisal

More information

Thoracic Recurrences. Soft tissue recurrence

Thoracic Recurrences. Soft tissue recurrence Stereotactic body radiotherapy for thoracic and soft malignancies Alexander Gottschalk, M.D., Ph.D. Associate Professor Director of CyberKnife Radiosurgery Department of Radiation Oncology University of

More information

Bone targeted radionuclide therapy. Val Lewington Royal Marsden Hospital, London

Bone targeted radionuclide therapy. Val Lewington Royal Marsden Hospital, London Bone targeted radionuclide therapy Val Lewington Royal Marsden Hospital, London Bone malignancy Primary bone tumours Bone malignancy Primary bone tumours - chemotherapy, surgery & external beam radiotherapy

More information

tomotherapy accurate treatment, fewer side effects bupacromwellhospital.com

tomotherapy accurate treatment, fewer side effects bupacromwellhospital.com tomotherapy accurate treatment, fewer side effects bupacromwellhospital.com The Bupa Cromwell Hospital radiotherapy department provides patients with a high quality of care and is led by a skilled and

More information

Oncologic Emergencies: When to call the Radiation Oncologist

Oncologic Emergencies: When to call the Radiation Oncologist Oncologic Emergencies: When to call the Radiation Oncologist Dr. Shrinivas Rathod Radiation Oncologist Radiation Oncology Program CancerCare Manitoba and University of Manitoba Disclosures Speaker s name:

More information

symposium article introduction symposium article

symposium article introduction symposium article Annals of Oncology 17 (Supplement 5): v118 v122, 2006 doi:10.1093/annonc/mdj965 Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/ vinblastine/doxorubicin/cisplatin

More information

DOWNLOAD OR READ : UNDERSTANDING LUNG CANCER PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : UNDERSTANDING LUNG CANCER PDF EBOOK EPUB MOBI DOWNLOAD OR READ : UNDERSTANDING LUNG CANCER PDF EBOOK EPUB MOBI Page 1 Page 2 understanding lung cancer understanding lung cancer pdf understanding lung cancer The two main types of lung cancer are non-small

More information

Re-irradiation for painful bone metastases: evidence-based approach

Re-irradiation for painful bone metastases: evidence-based approach Editor s note: Palliative Radiotherapy Column features articles emphasizing the critical role of radiotherapy in palliative care. Chairs to the columns are Dr. Edward L.W. Chow from Odette Cancer Centre,

More information

SYNOPSIS PROTOCOL N UC-0107/1602

SYNOPSIS PROTOCOL N UC-0107/1602 SYNOPSIS PROTOCOL N UC-0107/1602 A) TRIAL IDENTIFICATION SPONSOR PROTOCOL CODE NUMBER: UC-0107/1602 VERSION (NR & DATE): 0.1, MARCH 2016 TRIAL TITLE: Extracranial Stereotactic Body Radiation Therapy (SBRT)

More information

UPDATE ON RADIOTHERAPY

UPDATE ON RADIOTHERAPY 1 Miriam Kleiter UPDATE ON RADIOTHERAPY Department for Companion Animals and Horses, Plattform Radiooncology and Nuclear Medicine, University of Veterinary Medicine Vienna Introduction Radiotherapy has

More information

The Role of Radiotherapy in Metastatic Breast Cancer. Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health

The Role of Radiotherapy in Metastatic Breast Cancer. Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health The Role of Radiotherapy in Metastatic Breast Cancer Shilpen Patel MD, FACRO Associate Professor Departments of Radiation Oncology and Global Health Indications for Palliative Pain Control Radiation Bone

More information

TREAT SPINAL METASTASES WITH REPRODUCIBLE PRECISION

TREAT SPINAL METASTASES WITH REPRODUCIBLE PRECISION TREAT SPINAL METASTASES WITH REPRODUCIBLE PRECISION OsteoCool RF Ablation System YOUR EXPERTISE OUR INNOVATION The OsteoCool RF Ablation System is cooled radiofrequency ablation technology. It offers simultaneous,

More information

Focused ultrasound for treatment of bone tumours.

Focused ultrasound for treatment of bone tumours. Thomas Jefferson University Jefferson Digital Commons Department of Radiation Oncology Faculty Papers Department of Radiation Oncology 3-31-2015 Focused ultrasound for treatment of bone tumours. Dario

More information

TomoTherapy. Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA. May 2016

TomoTherapy. Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA. May 2016 TomoTherapy Michelle Roach CNC Radiation Oncology Liverpool Hospital CNSA May 2016 TomoTherapy The Facts Greek Tomo = slice Advanced form of IMRT 3D computerised tomography (CT) imaging immediately prior

More information

Current Management of Metastatic Bone Disease

Current Management of Metastatic Bone Disease Current Management of Metastatic Bone Disease Evaluation and Medical Management Dr. Sara Rask Head, Medical Oncology Simcoe Muskoka Regional Cancer Centre www.rvh.on.ca Objectives 1. Outline an initial

More information

White Rose Research Online URL for this paper: Version: Accepted Version

White Rose Research Online URL for this paper:  Version: Accepted Version This is a repository copy of From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Towards a Common Terminology and Classification

More information

Definition Prostate cancer

Definition Prostate cancer Prostate cancer 61 Definition Prostate cancer is a malignant neoplasm that arises from the prostate gland and the most common form of cancer in men. localized prostate cancer is curable by surgery or radiation

More information

RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES

RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES RADIONUCLIDE THERAPY FOR PALLIATION OF PAIN FROM BONY METASTASES Overview and Topics to Be Covered Reviews the use of radionuclide therapy in nuclear medicine for palliation of pain due to bony metastases.

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin)

Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin) Recent advances in the management of CRC II 2017/12/17 (Sun.) 10:10-11:00 Biomarkers to optimize treatment selection in colorectal cancer Edwin Pun HUI, MBChB, MD, FRCP (Lond & Edin) Department of Clinical

More information

Giving Opportunities Name Gift Associated Radiology Treatment Center $5 million

Giving Opportunities Name Gift Associated Radiology Treatment Center $5 million Beyond Extraordinary Giving Opportunities Name Associated Radiology Treatment Center Gastroenterology Center of Excellence Linear Accelerators (6) Courtyard/Garden Main Concourse/Waiting Area Gift $5 million

More information

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129 AD Award Number: W81XWH-10-1-1043 TITLE: FES-Rowing versus Zoledronic Acid to Improve Bone Health in SCI PRINCIPAL INVESTIGATOR: Leslie R. Morse, DO CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital,

More information

Cancer Of The Prostate (Basic And Clinical Oncology) By Sakti Das;Das S

Cancer Of The Prostate (Basic And Clinical Oncology) By Sakti Das;Das S Cancer Of The Prostate (Basic And Clinical Oncology) By Sakti Das;Das S If searched for a ebook Cancer of the Prostate (Basic and Clinical Oncology) by Sakti Das;Das S in pdf form, then you've come to

More information

Setting The study setting was secondary care. The economic study was undertaken in Spain.

Setting The study setting was secondary care. The economic study was undertaken in Spain. Zoledronic acid versus pamidronate: cost minimisation in bone metastasis Slof J, Badia X, Lizan L, Bautista F J, Echarri E, Hurle A D, Pla R, Mangues M A, Rodriguez-Sasiain J M, Wood M A Record Status

More information

Nordic Specialist Course in Palliative Medicine

Nordic Specialist Course in Palliative Medicine Nordic Specialist Course in MODULE 1 25-29 September 2017, Trondheim, Norway A. INTRODUCTION TO PALLIATIVE MEDICINE (1/2 day) To have an understanding of palliative medicine, its characteristics, advantages,

More information

OUR EXPERIENCE WITH ZOLEDRONIC ACID IN THE TREATMENT OF PATIENTS WITH NON- SMALL CELL LUNG CANCER AND BONE METASTASES

OUR EXPERIENCE WITH ZOLEDRONIC ACID IN THE TREATMENT OF PATIENTS WITH NON- SMALL CELL LUNG CANCER AND BONE METASTASES ISSN: 1312-773X (Online) DOI: 10.5272/jimab.2013191.391 Journal of IMAB - Annual Proceeding (Scientific Papers) 2013, vol. 19, issue 1 OUR EXPERIENCE WITH ZOLEDRONIC ACID IN THE TREATMENT OF PATIENTS WITH

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Tumours of the spinal cord Faculty of Clinical Radiology www.rcr.ac.uk Contents Primary spinal cord tumours

More information

CT-guided percutaneous pedicle screw fixation followed by cementoplasty in the treatment of metastatic spinal disease

CT-guided percutaneous pedicle screw fixation followed by cementoplasty in the treatment of metastatic spinal disease CT-guided percutaneous pedicle screw fixation followed by cementoplasty in the treatment of metastatic spinal disease Claudio Pusceddu Dpt of Interventional Radiology Oncological Hospital AOBrotzu Cagliari

More information

Impact of education: challenges and recommendations

Impact of education: challenges and recommendations Rigshospitalet Integrated Oncology and Palliative Care The Lancet Oncology Commission Impact of education: challenges and recommendations Per Sjøgren and Geana Kurita Palliative Research Group, Dept. Oncology,

More information

Pharmacogenetics and clinical opioid efficacy. Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway

Pharmacogenetics and clinical opioid efficacy. Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway Pharmacogenetics and clinical opioid efficacy Pål l Klepstad Professor of Intensive Care Medicine St.Olavs University Hospital Trondheim,, Norway Variation in opioid dose Variation in effects from different

More information

Importance of Attention. The Attention System 7/16/2013

Importance of Attention. The Attention System 7/16/2013 Importance of Attention Preliminary Evidence of an Association Between an IL6 Promoter Polymorphism and Self-Reported Attentional Function in Oncology Patients and Their Family Caregivers John Merriman,

More information

IVC History, Cancer Research

IVC History, Cancer Research Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 81-116) Cytokine Signaling Categories Heal the Wound! Angiogenesis - 62 Inflammation - 69 Differentiation - 53 Oncogene-Activation -

More information

Services Find a Doctor Locations and Directions Tools and Resources

Services Find a Doctor Locations and Directions Tools and Resources Find a Doctor Locations and Directions Tools and Resources Home > > Lung Lung Cell Risk Factors Lung is the word used to describe a group of diseases in which normal cells can also affect the tissue surrounding

More information

Prognostic factors in squamous cell anal cancers

Prognostic factors in squamous cell anal cancers Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus

More information

Isotopes and Palliative Radiotherapy for bone metastases

Isotopes and Palliative Radiotherapy for bone metastases Isotopes and Palliative Radiotherapy for bone metastases Rationale for Bone-seeking Isotope Therapies in Prostate Cancer > 90% of patients with advanced prostate cancer have bone metastases which can be

More information

Pètra Braam 1*, Philippe Lambin 2 and Johan Bussink 1

Pètra Braam 1*, Philippe Lambin 2 and Johan Bussink 1 Braam et al. Trials (2016) 17:61 DOI 10.1186/s13063-016-1178-7 STUDY PROTOCOL Open Access Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study

More information

J Clin Oncol 23: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 23: by American Society of Clinical Oncology INTRODUCTION VOLUME 23 NUMBER 21 JULY 20 2005 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine,

More information

Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First?

Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First? Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First? Marc Peeters, MD, PhD Head of the Oncology Department Antwerp University Hospital Antwerp, Belgium marc.peeters@uza.be 71-year-old

More information

Setting The setting was secondary care. The economic study was carried out in the UK.

Setting The setting was secondary care. The economic study was carried out in the UK. Cost-utility analysis of the GC versus MVAC regimens for the treatment of locally advanced or metastatic bladder cancer Robinson P, von der Masse H, Bhalla S, Kielhorn A, Aristides M, Brown A, Tilden D

More information

Plattenepithelkarzinom des Ösophagus, 1 st -line

Plattenepithelkarzinom des Ösophagus, 1 st -line Plattenepithelkarzinom des Ösophagus, 1 st -line AIO-STO-0309 An open-label, randomized phase III trial of cisplatin and 5-fluorouracil with or without panitumumab for patients with nonresectable, advanced

More information

Moving on useful clinical lessons learned in developing an International Classification System for Cancer Pain

Moving on useful clinical lessons learned in developing an International Classification System for Cancer Pain Robin Fainsinger, Cheryl Nekolaichuk. Division of Palliative Care Medicine, University of Alberta, and Covenant Health Palliative Institute, Edmonton, Canada Moving on useful clinical lessons learned in

More information

Principal Investigator. General Information. Conflict of Interest Published on The YODA Project (http://yoda.yale.edu)

Principal Investigator. General Information. Conflict of Interest Published on The YODA Project (http://yoda.yale.edu) Principal Investigator First Name: Antonio Last Name: Finelli Degree: MD, MSc, FRCSC Primary Affiliation: Princess Margaret Cancer Centre E-mail: antonio.finelli@uhn.ca Phone number: 416-946-4501 x2851

More information

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Reference: NHS England B01X09 First published: March 2016 Prepared by NHS England Specialised Services Clinical

More information

L arrotino - Kazimir Malevich RADIOTHERAPY. Patient information

L arrotino - Kazimir Malevich RADIOTHERAPY. Patient information L arrotino - Kazimir Malevich RADIOTHERAPY Patient information Index What is radiotherapy for? 3 Who works in a Radiotherapy Unit? 4 What does course of radiotherapy mean? 5 What is necessary before starting

More information

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT

THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT 1 THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT Jaegtvolden 4-5 June 2012 14. 12. 2012 2 1 3 WHO ANALGESIC LADDER (1996) NSAID +/- Adjuvant STEP II OPIODS Opids for mild to moderate

More information